This Alnylam promotional website is intended for UK Healthcare Professionals Only. Adverse Event Reporting information can be found at the bottom of the page. Prescribing Information links can be found with the content that they relate to.

RNAi therapies for HCPs

RNAi therapies for HCPs

GIVLAARI® (givosiran) - RNAi Therapy

Select below to explore educational, scientific and clinical resources related to the licensed uses of our therapies in the UK

Resources

The-ENVISION-Phase-3-Study-of-givosiran-in-AHP

Title

The ENVISION Phase 3 Study of givosiran in AHP

Material type

Slide Presentation

Description

This educational presentation shows data from the ENVISION Study which was the Phase 3, international, multi-centre trial of givosiran in AHP. Please note information in the presentation was correct at the time of presentation at AASLD 2025, please refer to the Prescribing Information for full details on givosiran.

Preparation Date

March 2026

Job Code

MB-UK-00131

Explore Additional Resources and Support

Attr

Acute Hepatic Porphyria (AHP)

To learn about Acute Hepatic Porphyria (AHP) therapeutic area

Didn't Find What You Were Looking For?

Contact our medical team for scientific information, support, and resources

Preparation Date

January 2026

Job Code

MB-UK-00037

Login and Sign up

Left Image

RNAiScience is for healthcare professionals. By creating an account, you will have access to:

- All RNAi on-demand educational content
- Personalisation experience with ability to bookmark content for future reference

First Name *

Last Name *

Enter your Institution Email *

Password *

Country *

GMC or GPhC or NMC Number

Select Speciality *

Select Profession *

* Required Fields

By signing up, you agree to our Terms of Service and Privacy Policy.